glp 1 osa GLP-1 receptor agonists, SGLT-2 inhibitors, and obstructive sleep apnoea: can new allies face an old enemy? Potential Use of GLP-1 and

All of these medications are weekly injections except for Saxenda, which is a daily injection and Rybelsus, which is an oral form of semaglutide

Acute kidney disease and acute kidney injury biomarkers in coronary care unit patients

Although significant progress has been made in the research on the pathogenesis of neurodegenerative diseases such as Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis and Huntingtons disease, and many drugs have found neuroprotective effects in cells and animal models, but there is still no drug that can produce clinical changes significantly in the pathogenesis

Therapeutic peptides aim to restore optimal signaling and support healthy aging